Pregnancy Preconception Care

The value of luteal support with progesterone in gonadotropin-induced cycles

Hamilton CJ, Jaroudi KA, Sieck UV

Published November 1993 Fertility and Sterility, 60(5), 786-790
DOI 10.1016/s0015-0282(16)56277-3 PMID 8224262

RRM Academy Synopsis

Pregnancy rates rose with luteal progesterone in gonadotropin cycles

Pregnancy followed in about 26 out of 100 cycles with vaginal progesterone luteal support, against about 10 out of 100 cycles without it, in a retrospective study of women given gonadotropin injections. The gap was larger in women who did not ovulate with clomiphene. It was not significant in women with low pituitary hormone levels.

Key Findings

  • The overall pregnancy rate was 26.3% in 118 cycles with luteal support and 10.4% in 115 control cycles without it (P < 0.001).
  • In women with clomiphene citrate-resistant anovulation, 26 pregnancies occurred in 103 cycles with luteal support (25.2%) and six pregnancies in 87 cycles without it (6.9%).
  • In women with hypogonadotropic amenorrhea, 5 out of 15 cycles with luteal support (33.3%) and 6 of 28 cycles without it (21.4%) resulted in clinical pregnancy; the difference was not significant.
  • The abortion rate, the paper's term for pregnancy loss, was 33.3% with luteal support and 35.5% without, a difference that was not significant.

Interpretation

The paper is a retrospective comparison of two consecutive treatment periods. No luteal support was given from March 1988 to February 1989. Vaginal progesterone was given routinely from March 1989 to January 1990. The induction protocol and patient selection stayed otherwise unchanged. Outcomes are counted per cycle, and the groups were similar in age, duration of infertility, height and weight. The analysis excluded women whose infertility involved a tubal, cervical or male cause, and it excluded in vitro fertilization cycles. The authors note that a randomized, placebo-controlled trial would give a more definitive answer.

RRM Context

RRM views the luteal phase as part of the ovulatory cycle. The authors infer a relative progesterone deficiency in many stimulated cycles. They suggest that the need for extra progesterone relates to the cause of the ovarian disturbance. Reasoning from the cause of ovulatory dysfunction is a central principle of RRM.

Abstract

Objective

To evaluate the effect of luteal support with vaginal P suppositories in hMG- and hCG-induced cycles.

Design

Between March 1988 and February 1989 patients did not receive luteal support, while between March 1989 and January 1990 P was given routinely in the luteal phase. Induction protocol and patient selection remained otherwise unchanged.

Setting

Infertility clinic of a tertiary care hospital.

Patients

Twenty-seven patients with hypogonadotropic amenorrhea (World Health Organization [WHO] group I) (11 women with luteal support, 16 women without) and 102 patients with euprolactinemic clomiphene citrate (CC)-resistant anovulation (WHO group II) (52 women with luteal support, 50 women without).

Intervention

Vaginal P suppositories 200 mg/d in the luteal support group.

Main Outcome Measures

Pregnancy rate (PR), pregnancy outcome.

Results

The overall PR in 118 cycles with luteal support was 26.3% whereas 10.4% pregnancies were achieved in 115 cycles of the control group. The influence of luteal support was more pronounced in patients with CC-resistant anovulation (25.2% versus 6.9%) than in patients with hypogonadotropic amenorrhea (33.3% versus 21.4%, not significant). The abortion rate was not significantly changed.

Conclusion

Luteal support with P increases the PR after hMG and hCG induction. The need for supplementary P seems to be related to the underlying cause of ovarian disturbance.

Topics

By this author

Related research

Pregnancy › Preconception Care › Preconception Optimization · Reproductive Endocrinology › Luteal Phase › Progesterone Support · Therapeutics › Hormonal Agents › Progesterone and Progestins
Carl J. C. M. Hamilton, Kamal A. Jaroudi, Ulla V. Sieck
C Hamilton, K Jaroudi, U Sieck
PMID 8224262 8224262 DOI 10.1016/s0015-0282(16)56277-3 10.1016/s0015-0282(16)56277-3 Hamilton et al. 1993, Hamilton 1993